# ClinicalTrials.gov record NCT02474914

> PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct02474914-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-08-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02474914-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02474914-octreotide-v1.json
- Content SHA-256: `89d1e339aa17f6e481a4cf68c9fc2ebc8094b2021ed10b826953080cd26a65f0`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02474914 ([`ctg-observation-nct02474914-2017-08-22-8bd8733723af`](#source-ctg-observation-nct02474914-2017-08-22-8bd8733723af))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02474914-2017-08-22-8bd8733723af`](#source-ctg-observation-nct02474914-2017-08-22-8bd8733723af))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02474914-2017-08-22-8bd8733723af`](#source-ctg-observation-nct02474914-2017-08-22-8bd8733723af))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02474914-2017-08-22-8bd8733723af`](#source-ctg-observation-nct02474914-2017-08-22-8bd8733723af))

## Sources

<a id="source-ctg-observation-nct02474914-2017-08-22-8bd8733723af"></a>
- **ClinicalTrials.gov record NCT02474914 · retained source version 2017-08-22:8bd8733723afe20d8c1079d80c9a16ac486b28e6f9c694a23498ff1bc503c28e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02474914) (`ctg-observation-nct02474914-2017-08-22-8bd8733723af`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02474914." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02474914-octreotide-v1.json SHA-256: 89d1e339aa17f6e481a4cf68c9fc2ebc8094b2021ed10b826953080cd26a65f0.